Sri Lanka, July 30 -- Sri Lanka pharmaceutical manufacturers have the potential to tap the global pharmaceutical industry worth USD 1.8 trillion, Sri Lanka Pharmaceutical Manufacturers' Association (SLPMA) President Dinesh Athapaththu told the 60th SLPMA Annual General Meeting (AGM) held in Colombo on July 27.

He also reaffirmed SLPMA's commitment towards advancing Sri Lanka's pharmaceutical self-reliance and strengthening the country's position as a credible pharmaceutical manufacturing hub held under the theme "Driving the National Call Forward."

Athapaththu highlighted the need of transforming the industry's long-term vision into tangible action by accelerating progress across five strategic pillars, enabling policy support, progress...